VBI Vaccines, Inc. is a biopharmaceutical company, which engages in the development of infectious disease and immuno-oncology vaccines. The firm focuses on the prevention and treatment of hepatitis B through its product pipeline, Sci-B-Vac and VBI-2601. It also develops an enveloped virus-like particle (eVLP) platform technology, which allows the development of eVLP vaccines that closely mimic the target virus to elicit a potent immune response. The company was founded on April 9, 1965 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of VBI Vaccines Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. VBI Vaccines Inc. market cap is $14,341.00.
What is the 52-week high for VBI Vaccines Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. VBI Vaccines Inc. 52 week high is $0.0505 as of February 17, 2026.
What is VBI Vaccines Inc. stock price today?
VBI Vaccines Inc. stock price today is $0.0005.
What was VBI Vaccines Inc. stock price yesterday?
VBI Vaccines Inc. stock price yesterday was $0.0005.
What is the Price-to-Book ratio of VBI Vaccines Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. VBI Vaccines Inc. P/B ratio is -0.0023.
What is the 50-day moving average of VBI Vaccines Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. VBI Vaccines Inc. 50-day moving average is $0.0005.